Department of Clinical Pharmacy, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Department of Pharmacy, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
J Innate Immun. 2024;16(1):337-353. doi: 10.1159/000539502. Epub 2024 May 31.
Sepsis-associated coagulopathy specifically refers to widespread systemic coagulation activation accompanied by a high risk of hemorrhage and organ damage, which in severe cases manifests as disseminated intravascular coagulation (DIC), or even develops into multiple organ dysfunction syndrome (MODS). The complement system and the coagulation system as the main columns of innate immunity and hemostasis, respectively, undergo substantial activation after sepsis.
Dysfunction of the complement, coagulation/fibrinolytic cascades caused by sepsis leads to "thromboinflammation," which ultimately amplifies the systemic inflammatory response and accelerates the development of MODS. Recent studies have revealed that massive activation of the complement system exacerbates sepsis-induced coagulation and even results in DIC, which suggests that inhibition of complement activation may have therapeutic potential in the treatment of septic coagulopathy.
Sepsis-associated thrombosis involves the upregulation or activation of procoagulant factors, down-regulation or inactivation of anticoagulant factors, and impairment of the fibrinolytic mechanism. This review aims to summarize the latest literature and analyze the underlying molecular mechanisms of the activation of the complement system on the abnormal coagulation cascades in sepsis.
脓毒症相关性凝血病特指广泛的全身性凝血激活,伴有高出血风险和器官损伤,在严重情况下表现为弥散性血管内凝血(DIC),甚至发展为多器官功能障碍综合征(MODS)。补体系统和凝血/纤维蛋白溶解级联系统分别作为先天免疫和止血的主要支柱,在脓毒症后会发生实质性激活。
脓毒症引起的补体、凝血/纤维蛋白溶解级联功能障碍导致“血栓炎症”,最终放大全身炎症反应并加速 MODS 的发展。最近的研究表明,补体系统的大量激活会加重脓毒症引起的凝血,甚至导致 DIC,这表明抑制补体激活可能在治疗脓毒症性凝血病方面具有治疗潜力。
脓毒症相关性血栓形成涉及促凝因子的上调或激活、抗凝因子的下调或失活以及纤维蛋白溶解机制的损害。本综述旨在总结最新文献,并分析补体系统在脓毒症异常凝血级联中的激活对其产生影响的潜在分子机制。